The Impact of the First 2020 COVID-19 Lockdown on the Metabolic Control of Patients with Phenylketonuria

by Dariusz Walkowiak, Bożena Mikołuć, Renata Mozrzymas, Łukasz Kałużny, Bożena Didycz, Joanna Jaglowska, Danuta Kurylak, Jarosław Walkowiak
Published 2021-06-01

Vitamin K Status in Adherent and Non-Adherent Patients with Phenylketonuria: A Cross-Sectional Study

by Renata Mozrzymas, Dariusz Walkowiak, Sławomira Drzymała-Czyż, Patrycja Krzyżanowska-Jankowska, Monika Duś-Żuchowska, Łukasz Kałużny, Jarosław Walkowiak
Published 2020-06-01

Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II

by Miroslaw Bik-Multanowski, Ewa Jamroz, Lukasz Kaluzny, Ewa Pronicka, Dariusz Rokicki, Ewa Starostecka, Jolanta Sykut-Cegielska, Mieczyslaw Walczak
Published 2016-03-01

<i>Helicobacter pylori</i> Infection in Children with Phenylketonuria Does Not Depend on Metabolic Control and Is Not More Frequent Than in Healthy Subjects—A Cross-Sectional Study...

by Marek Walkowiak, Łukasz Kałużny, Renata Mozrzymas, Małgorzata Jamka, Bożena Mikołuć, Joanna Jagłowska, Ewa Starostecka, Roza Nurgaliyeva, Jarosław Walkowiak, Aleksandra Lisowska
Published 2021-08-01

The Impact of the COVID-19 Pandemic on the Perception of Health and Treatment-Related Issues among Patients with Phenylketonuria in Poland—The Results of a National Online Survey

by Dariusz Walkowiak, Bożena Mikołuć, Renata Mozrzymas, Łukasz Kałużny, Bożena Didycz, Dorota Korycińska-Chaaban, Michał Patalan, Joanna Jagłowska, Agnieszka Chrobot, Ewa Starostecka, Joanna Zarębska, Jarosław Walkowiak
Published 2021-06-01